Salarius Pharmaceuticals announces $6M private placement priced ATM
- Salarius Pharmaceuticals (NASDAQ:SLRX) has entered into definitive agreements for the issuance and sale of an aggregate of 3.64M shares of its common stock, Series A-1, A-2 warrants of ~3.64 shares respectively, at a purchase price of $1.65/share priced ATM under Nasdaq rules.
- The gross proceeds are expected to be ~$6M and the Co. intends to use the net proceeds from the private placement for further development of its product candidates and working capital and general corporate purposes.
- The private placement is expected to close on or about May 16, 2023.